GE Medical Systems has made its first commercial installation of Senographe 2000D, the company’s full-field digital mammography system. The unit received the CE Mark for European regulatory clearance this spring (SCAN 3/17/99), and on Sept. 2
GE Medical Systems has made its first commercial installation of Senographe 2000D, the companys full-field digital mammography system. The unit received the CE Mark for European regulatory clearance this spring (SCAN 3/17/99), and on Sept. 2 Senographe was placed at Charite Hospital in Berlin. The Milwaukee-based firm plans to install more than 50 Senographes outside the U.S. by the end of the year.
Senographe 2000Ds digital detector is based on amorphous silicon flat-panel detectors manufactured in the companys plant in Santa Clara, CA, a joint venture between GE and EG&G Amorphous Silicon (SCAN 9/3/97) The detectors are then shipped to France, where they are incorporated into Senographe systems built at the companys x-ray and mammography factory in Buc.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.